Denali Therapeutics Inc (DNLI)
Healthcare
Biotechnology
23.00 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Denali Therapeutics Inc (DNLI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -413 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -72 | -77 | 50 | -152 | 416 | -211 | -245 | -358 | -348 | -413 | |
| 0.1 | 1.5 | 3.1 | 7.4 | 8.0 | 8.5 | 8.6 | 10 | 17 | 9.0 | 15 | |
| 0.5 | 3.0 | 4.4 | 19 | 38 | 50 | 85 | 100 | 108 | 103 | 100 | |
| 1.2 | 8.5 | 5.2 | 19 | 38 | 50 | 91 | 95 | – | – | – | |
| 0.4 | 4.3 | 3.3 | 63 | 2.9 | 288 | -20 | -24 | -290 | 17 | 0.1 | |
| 3.1 | 6.1 | 2.9 | 3.4 | 18 | 3.1 | 8.5 | 18 | 13 | 16 | 9.5 | |
| -3.1 | -219 | -41 | -287 | 148 | -623 | -22 | -141 | 249 | -89 | 255 | |
| 44 | 300 | 296 | 2.6 | 6.2 | 215 | 19 | – | – | – | – | |
| 5.0 | – | – | – | – | – | – | 0.0 | 0.0 | -32 | -8.2 | |
| 49 | 300 | 296 | 97 | 6.2 | 635 | 19 | 311 | 18 | 484 | 189 | |
| 31 | 9.1 | 179 | -140 | 2.3 | 428 | -214 | -75 | -91 | 48 | 32 | |
| -18 | -78 | -80 | 47 | -169 | 413 | -220 | -263 | -371 | -364 | -422 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.